Austar Lifesciences Ltd.'s market cap is currently HK$415.19M. The company's EPS TTM is HK$-0.142; its P/E ratio is ―; Austar Lifesciences Ltd. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 1.76B	¥ 2.23B	¥ 2.02B	¥ 1.30B	¥ 1.05B
Gross Profit	¥ 336.05M	¥ 462.67M	¥ 479.01M	¥ 323.53M	¥ 284.24M
Operating Income	¥ -29.99M	¥ 90.39M	¥ 116.97M	¥ 26.38M	¥ 2.65M
EBITDA	¥ 25.15M	¥ 166.13M	¥ 130.62M	¥ 39.83M	¥ 14.40M
Net Income	¥ -113.47M	¥ 87.46M	¥ 277.30M	¥ 33.10M	¥ 8.09M
Balance Sheet
Cash & Short-Term Investments	¥ 173.76M	¥ 148.13M	¥ 219.74M	¥ 178.11M	¥ 191.29M
Total Assets	¥ 2.16B	¥ 2.39B	¥ 2.04B	¥ 1.38B	¥ 1.17B
Total Debt	¥ 496.20M	¥ 336.55M	¥ 155.22M	¥ 76.47M	¥ 58.45M
Net Debt	¥ 332.43M	¥ 202.92M	¥ -43.22M	¥ -101.48M	¥ -132.64M
Total Liabilities	¥ 1.38B	¥ 1.51B	¥ 1.26B	¥ 854.27M	¥ 671.70M
Stockholders' Equity	¥ 773.01M	¥ 896.94M	¥ 786.58M	¥ 517.90M	¥ 494.54M
Cash Flow
Free Cash Flow	¥ -133.59M	¥ -155.25M	¥ -204.02M	¥ 25.68M	¥ 24.07M
Operating Cash Flow	¥ -62.65M	¥ -37.93M	¥ -103.45M	¥ 52.22M	¥ 37.79M
Investing Cash Flow	¥ -54.47M	¥ -153.14M	¥ 65.02M	¥ -59.81M	¥ -22.09M
Financing Cash Flow	¥ 147.12M	¥ 125.30M	¥ 59.35M	¥ -5.51M	¥ -20.69M

Currency in CNY

Austar Lifesciences Ltd. Earnings and Revenue History

Income Statement >

Austar Lifesciences Ltd. Debt to Assets

Balance Sheet >

Austar Lifesciences Ltd. Cash Flow

Cash Flow >

Austar Lifesciences Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing